| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |